The Staff Investigators at UPCI are excellent physician scientists providing distinctive leadership in the scientific endeavors of UPCI that extends beyond their individual research activities. They are innportant contributors to the interprogramnnatic activities and fulfill the translational objectives ofthe scientific programs. Dr. David Bartlett is a Clinical Staff Investigator providing a significant contribution to the clinical research activities of UPCI. He provides oversight for the multidisciplinary specialty care clinics, tumor boards and provides integration of the clinicla research activities as they relate to each disease site. Dr. Soldano Ferrone is a Research Staff Investigator with extensive experience in cancer biology and immunotherapy. He serves a unique role as a resource for the scientific community at UPCI to design immunixation protocols, screening procedures and characterization strategies of antibodies to clinically relevant molecules. This library of monoclonal antibodies represents a useful source of reagents for the entire UPCI reseach community. Dr. Ferrone is also involved in the research and career development of junior faculty and is responsible for the mentorship program for junior faculty. Dr. IVIichael Lotze has a unique role in UPCI and develops relationships with outside academic institutions, biotechnology and pharaceutical firms of strategic importance forthe UPCI. He is the UPCI representative to the Cancer Biology Training Consortium (CABTRAC) and is a mentor to several UPCI junior faculty. We are requesting support for 1.2 calendar months for each of these three UPCI Staff Investigators who have major programmatic responsibilities.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA047904-26
Application #
8705402
Study Section
Special Emphasis Panel (ZCA1-RTRB-L)
Project Start
Project End
Budget Start
2014-08-01
Budget End
2015-07-31
Support Year
26
Fiscal Year
2014
Total Cost
$55,526
Indirect Cost
$18,794
Name
University of Pittsburgh
Department
Type
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Wang, Yue; Wang, Zehua; Xu, Jieni et al. (2018) Systematic identification of non-coding pharmacogenomic landscape in cancer. Nat Commun 9:3192
Lee, Young-Sun; Lee, Dae-Hee; Choudry, Haroon A et al. (2018) Ferroptosis-Induced Endoplasmic Reticulum Stress: Cross-talk between Ferroptosis and Apoptosis. Mol Cancer Res 16:1073-1076
Tong, Jingshan; Zheng, Xingnan; Tan, Xiao et al. (2018) Mcl-1 Phosphorylation without Degradation Mediates Sensitivity to HDAC Inhibitors by Liberating BH3-Only Proteins. Cancer Res 78:4704-4715
Menk, Ashley V; Scharping, Nicole E; Rivadeneira, Dayana B et al. (2018) 4-1BB costimulation induces T cell mitochondrial function and biogenesis enabling cancer immunotherapeutic responses. J Exp Med 215:1091-1100
Caves, Elizabeth A; Cook, Sarah A; Lee, Nara et al. (2018) Air-Liquid Interface Method To Study Epstein-Barr Virus Pathogenesis in Nasopharyngeal Epithelial Cells. mSphere 3:
Saydmohammed, Manush; Vollmer, Laura L; Onuoha, Ezenwa O et al. (2018) A High-Content Screen Reveals New Small-Molecule Enhancers of Ras/Mapk Signaling as Probes for Zebrafish Heart Development. Molecules 23:
Gough, Albert; Shun, Tong Ying; Taylor, D Lansing et al. (2018) Integrating Analysis of Cellular Heterogeneity in High-Content Dose-Response Studies. Methods Mol Biol 1745:25-46
Fletcher, Rochelle; Wang, Yi-Jun; Schoen, Robert E et al. (2018) Colorectal cancer prevention: Immune modulation taking the stage. Biochim Biophys Acta Rev Cancer 1869:138-148
Li, Xiang; George, Subin M; Vernetti, Lawrence et al. (2018) A glass-based, continuously zonated and vascularized human liver acinus microphysiological system (vLAMPS) designed for experimental modeling of diseases and ADME/TOX. Lab Chip 18:2614-2631
Singh, Renu; Mehrotra, Shailly; Gopalakrishnan, Mathangi et al. (2018) Population pharmacokinetics and exposure-response assessment of veliparib co-administered with temozolomide in patients with myeloid leukemias. Cancer Chemother Pharmacol :

Showing the most recent 10 out of 1187 publications